In layman's terms, Benign Prostatic Hyperplasia = Big Prostate. And it is not the same as prostate cancer.
In layman’s terms, Benign Prostatic Hyperplasia = Big Prostate. And it is not the same as prostate cancer.
The prostate is a walnut-shaped gland that is part of the male reproductive system. The main function of the prostate is to make a fluid that goes into semen. Prostate fluid is essential for a man’s fertility.
The prostate is located just below the bladder and in front of the rectum and surrounds the urethra (the tube that empties urine from the bladder).
The prostate goes through two main growth periods as a man ages. The first occurs early in puberty when the prostate doubles in size. The second phase of growth begins around age 25 and continues during most of a man’s life. Benign prostatic hyperplasia often occurs with the second growth phase.
This can cause the urethra to narrow and reduce urine flow. For some men, the reduction in the flow of urine can be significant. Some symptoms include:
More severe symptoms include:
Very common.
In 2010, as many as 14 million men in the United States had lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
About half of men between 51 and 60 develop the condition, and that number steadily climbs in the decades that follow. And up to 90 percent of men older than 80.
To diagnose BPH, Dr. Nanavati evaluates a patient’s medical history, performs a physical exam, and runs diagnostic tests.
As a first step, Dr. Nanavati will collect information about the patient’s medical history. Typically questions center on urinary symptoms associated with BPH including urination frequency, nighttime urination habits, the feeling of incomplete bladder emptying and urgency to urinate, and whether the patient needs to strain to urinate. Dr. Nanavati may also ask about daily fluid intake, consumption of caffeine and alcohol, and whether the patient takes medications that can affect urination.
In most cases, Dr. Nanavati will order some additional tests to help confirm a diagnosis of BPH, including bloodwork to measure the levels of prostate-specific antigen (PSA), a protein produced by the prostate gland. Elevated levels of PSA may be a sign of an enlarged prostate.
A urinalysis, a test in which a patient urinates into a container, is sometimes recommended. This test checks for signs of a urinary tract infection, blood in the urine (hematuria), and kidney function.
Dr. Nanavati may also recommend other tests that measure the rate of urine flow and the amount of urine that remains in the bladder after urination. Dr. Nanavati will also order an ultrasound of the prostate and/or a cystoscopy, a procedure in which a cystoscope—a tube equipped with a small lens—is inserted into the urethra to allow the doctor to examine the urethra and bladder.
Several risk factors increase the chances that a man will develop BPH:
You will be at risk of complications such as
Treatment options for benign prostatic hyperplasia may include
A health care provider treats benign prostatic hyperplasia based on the severity of symptoms, how much the symptoms affect a man’s daily life, and a man’s preferences.
Men may not need treatment for a mildly enlarged prostate unless their symptoms are bothersome and affect their quality of life. In these cases, instead of treatment, a urologist may recommend regular checkups. If benign prostatic hyperplasia symptoms become bothersome or present a health risk, a urologist most often recommends treatment.
Yes. Unlike invasive surgery, Dr. Nanavati, an experienced Interventional Radiologist, performs an image-guided outpatient procedure avoiding surgery while preserving your uterus & ovaries, controlling symptoms, and significantly improving your quality of life. Isn’t this amazing? Approximately 9 out of 10 women who undergo uterine fibroid embolization will experience significant symptomatic fibroids improvement.
PAE is a non-surgical treatment alternative for men with severe BPH who have failed medical therapy and who do not wish to undergo or are ineligible for surgery.
PAE can help elderly patients with large prostates with high resection volume and can provide an effective alternative to conventional surgery.
Dr. Nanavati will meet with you to review your medical history and imaging studies. Together, we will determine whether PAE is right for you.
Some medications should be stopped or reduced – you should discuss your medications with your doctor. You should fast for at least 6 hours before the procedure, though water can be taken with your normal medications. Before the intervention, you will receive some antibiotics to prevent infection.
The excessive Prostatic growth reduces the quality of life for many men as it ‘pinches’ the urethra and prevents complete emptying of the bladder, resulting in the need to pass urine very frequently, including during the night, disturbing sleep. The purpose of prostatic artery embolization (PAE) is to limit the symptoms of BPH by reducing the blood supply to the prostate gland, causing it to shrink.
Under X-ray guidance and sedation, Dr. Nanavati will access the artery through a small incision in the wrist or groin. Dr. Nanavati then guides a very thin catheter (about the size of a strand of spaghetti) into the incision and through your blood vessels to the Prostatic artery.
Once the catheter is in the proper position, the doctor releases small particles(like tiny sand granules) at the targeted location to block the small vessels and deprive the prostate of nutrients. Prostate artery embolization is performed in both Prostatic arteries. At the completion of the embolization procedure, pressure is applied to the small incision to allow it to heal. Outpatient Procedure, you’ll be sent home with oral pain medication to use for an additional few days.
This outpatient procedure takes around 1-3 hours and the patient will return home later that day. Procedures may take between 1 and 3 hours depending on how the prostatic veins are located or are large. The PAE procedure blocks blood flow in the regions of the prostate most vulnerable to BPH and causes death in isolated areas.
Immediately after embolization, your prostate will no more have blood to supply it so it shrinks to smaller dimensions. The bladder outflow opens, and thus able to empty more efficiently.
Many men are able to resume their normal daily activities within 3 days of their procedure.
In most cases, relief begins to occur within a week, as the prostate starts to shrink, relieving the pressure on the urethra and improving lower urinary tract symptoms.
Much less frequent & less severe than invasive surgery.
Risks include but are not limited to temporary urinary retention, Infections of the prostate and Bladder, and Irreparable damage to an artery. A collection of blood beneath a skin surface (hematomas) on a punctured area of the groin. Most of them are self-limited and easily manageable.
Patient follow-ups are 2 weeks, 2 months, 6 months, and 1 year after the procedure.
A catheter is used for urination. If you are already foley dependent then expect to have it removed in a follow-up(1-2 weeks) visit. Patients who had no previous dependency on a catheter usually be withdrawn shortly after their PAE procedures. In small cases, you may leave home with a Foley catheter, which will be removed in a follow-up appointment.
PAE is a newer, faster, safer, minimally invasive treatment and an easier way to relieve the symptoms caused by BPH. As compared to various surgical options (Transurethral resection (TURP, TUIP), Open prostatectomy), PAE patients had a significantly more pronounced mean decrease in prostate size resulting in several benefits. An outpatient procedure, Shorter Recovery time, Low risk of sexual side effects, low risk of urinary incontinence, no retrograde ejaculation, no indwelling foley catheter, and decrease pain and discomforts.
You are not alone. See survey results below.
Apart from the most common indication for Benign prostatic hyperplasia, is indicated in Prostatic cancer for symptom relief, Hematuria(blood in urine) from the Prostate origin, etc.
Researchers have not found a way to prevent benign prostatic hyperplasia.